What is the difference between primary use and secondary use of electronic health data in EHDS?

Why primary use and secondary use are separated in EHDS

Primary use is the clinical side of the European Health Data Space: data used to care for the patient in front of you, support diagnosis, treatment, and other direct health service needs. Secondary use is the governed reuse of that data for broader permitted purposes such as research, policy, innovation, and system planning. The split matters because each use case carries different access and oversight rules.

The practical implication is that the same health record can sit in two different governance paths depending on why it is being accessed. In primary use, the emphasis is continuity of care and timely access. In secondary use, the emphasis shifts to lawful reuse, role eligibility, purpose limitation, and controls that reduce unnecessary exposure while still enabling approved societal uses.

That is why EHDS is not just a data-sharing scheme. It creates a policy boundary between care delivery and reuse, so organisations need to know which workflow they are in before they decide who can see the data, what form the data should take, and what oversight applies.

What changes in practice between the two use cases

Primary use is usually operational and patient-facing, so the standard for access is tied to care delivery, clinical duty, and the immediate need to act. Secondary use is more conditional: the request must fit an allowed purpose, pass the relevant governance checks, and often rely on a controlled access path rather than direct access to identifiable records.

That difference affects more than legal wording. It changes who can ask for data, what the recipient is allowed to do with it, and what form of data is appropriate. For secondary use, the practical preference is generally for the minimum data necessary, with stronger safeguards where identifiability is not needed. A useful way to think about this is to treat the EHDS framework itself as a split between care access and governed reuse, not as one generic access model.

For practitioners, the hardest part is often not the policy text but the workflow design. If a team cannot tell whether a request is primary or secondary use, it is easy to apply the wrong approval route, overexpose data, or delay legitimate care access while trying to satisfy research or analytics needs.

EHDS also sits alongside wider healthcare compliance work. Teams already operating under healthcare cyber regulation mapping need to align EHDS use classification with privacy, security, and sector obligations rather than treating it as a standalone data project.

Why governance, access control, and data minimisation matter most

Secondary use increases the governance burden because the same dataset may be reused across multiple institutions, projects, or policy objectives. That creates a higher risk of scope creep, especially if organisations rely on broad internal interpretations of “research” or “innovation” instead of a documented permitted-use assessment.

Primary use has a different risk profile. The main concern is not reuse scope, but ensuring that clinicians and care teams can get the right information at the right time without weakening confidentiality or traceability. In practice, the control challenge is to separate urgency from entitlement. One health data control model may help with the familiar security mechanics, but EHDS still requires a use-based decision before access is granted.

Secondary use also raises disclosure minimisation issues. Even when a use is allowed, the data shared should still reflect the purpose, the legal basis, and the need to reduce re-identification risk. That is why governance should ask three questions every time: is this primary or secondary use, is the purpose allowed, and is the dataset more identifiable than the purpose requires?

Risk and Threat Considerations

The main risk is misclassification: treating secondary use as if it were routine care access can overexpose personal health data, while treating primary use as if it were secondary use can slow care delivery and create unsafe workflow delays. The same confusion can also lead to weak audit trails, purpose drift, and poor accountability when data is reused beyond the original clinical context.

Failure mechanism: A request is approved under the wrong access path, so the organisation either discloses more data than the use allows or blocks access that clinicians genuinely need. Over time, that can normalise loose purpose checks and make later governance reviews unreliable.

Impact: The result can be unlawful reuse, unnecessary privacy exposure, weaker trust in data-sharing programmes, and operational friction between care teams, data holders, and secondary users.

Practitioner Guidance

What to verify: Confirm that your organisation has a documented decision rule for classifying each request as primary or secondary use before the data is released. The classification should be visible in the workflow, not inferred after the fact.

Decision rule: If the data is being accessed to support treatment, diagnosis, or direct care, route it through the primary-use path. If the request is for research, planning, or another non-care purpose, require the secondary-use controls, purpose review, and the narrower dataset needed for that purpose.

What practitioners underestimate: The boundary is not only legal, it is operational. Good EHDS governance depends on consistent classification, because the access model, oversight burden, and acceptable data shape all change with the use case.

Practitioner takeaway: The safest implementation is the one that makes the use distinction explicit at the point of request, because once primary and secondary use blur, both compliance and data protection start to fail.

Related resources from NHI Mgmt Group

• What is the difference between collecting data for public health and retaining data for future secondary use?
• Primary Use Of Health Data
• Secondary Use Of Health Data
• How should security teams de-identify health data for HIPAA in a way that preserves enough utility for analytics and AI use cases?